BPN pharmacology consulting services in relation to pharmaceutical development
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00112
- Awardee
-
Detke Biopharma Consulting LLC UEI JNL4KCLVVLT7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $33,000
Award facts
- Opportunity
-
- BPN EOC Pharmacology Consultation Services Solicitation · 75N95022Q00027 · Posted Jan 7, 2022
- Contract value 47% obligated
-
- $33,000.00 Current, with exercised options
- $70,500.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 7 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Carmel, IN 46033, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $11,500 | |
| Other Administrative Action | $11,500 | |
| Original award | $10,000 |
About this award
This purchase order award from the Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke to Detke Biopharma Consulting LLC is for $70,500 to provide pharmacology consulting services in support of the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs through February 2025. As a member of the BPN External Oversight Committee, the contractor will provide strategic guidance and technical feedback on BPN projects and other NIH drug development initiatives. The underlying solicitation sought a subject matter expert in pharmacology to advise NIH leadership on projects within the BPN portfolio, which provides neuroscience researchers with industry-style support through Phase I clinical trials. This total small business set-aside award was issued under the terms of the BPN program.
Quick answers
Who was awarded contract 75N95022P00112?
75N95022P00112 was awarded to Detke Biopharma Consulting LLC by National Institute on Drug Abuse (National Institutes of Health) on February 23, 2022.
How much is contract 75N95022P00112 worth?
The government has obligated $33,000 on 75N95022P00112. Its potential value, with all options, is $70,500.
Which agency awarded contract 75N95022P00112?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00112, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95022P00112 competed?
The extent of competition for 75N95022P00112 was competed under sap. The government received 7 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award